IGEM-E

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameIGEM-E
Drug Alias NameIGEM-E
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionEpidermal growth factor receptor erbB1 antagonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsHead and Neck NeoplasmsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEpsilogen Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEpsilogen Ltd
Active IndicationsN/A
Inactive IndicationsHead and Neck NeoplasmsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A